Healthcare provider profile · identity verified

Jenifer D Coffman, FNP

Nurse Practitioner · SOUTH BEND, IN · NPI 1336745504

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	271	33
Atorvastatin Calcium	Atorvastatin Calcium	240	70
Amlodipine Besylate	Amlodipine Besylate	208	52
Levothyroxine Sodium	Levothyroxine Sodium	205	50
Furosemide	Furosemide	146	36
Sertraline Hcl	Sertraline Hcl	141	29
Gabapentin	Gabapentin	136	28
Omeprazole	Omeprazole	115	28
Alprazolam	Alprazolam	108	17
Quetiapine Fumarate	Quetiapine Fumarate	106	17
Pantoprazole Sodium	Pantoprazole Sodium	104	22
Potassium Chloride	Potassium Chloride	100	23
Lisinopril	Lisinopril	92	26
Donepezil Hcl	Donepezil Hcl	86	14
Chlorthalidone	Chlorthalidone	85	15
Metformin Hcl	Metformin Hcl	85	25
Pravastatin Sodium	Pravastatin Sodium	83	18
Losartan Potassium	Losartan Potassium	81	26
Metoprolol Tartrate	Metoprolol Tartrate	80	22
Trazodone Hcl	Trazodone Hcl	75	15
Buspirone Hcl	Buspirone Hcl	71	15
Rosuvastatin Calcium	Rosuvastatin Calcium	71	14
Eliquis	Apixaban	69	21
Escitalopram Oxalate	Escitalopram Oxalate	66	16
Montelukast Sodium	Montelukast Sodium	63	17
Tamsulosin Hcl	Tamsulosin Hcl	61	14
Albuterol Sulfate Hfa	Albuterol Sulfate	57	21
Metoprolol Succinate	Metoprolol Succinate	55	20
Simvastatin	Simvastatin	55	suppressed
Mirtazapine	Mirtazapine	50	11
Tramadol Hcl	Tramadol Hcl	50	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	12
Duloxetine Hcl	Duloxetine Hcl	47	17
Hydroxyzine Hcl	Hydroxyzine Hcl	47	13
Levetiracetam	Levetiracetam	47	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	suppressed
Prednisone	Prednisone	43	23
Carvedilol	Carvedilol	42	14
Fluticasone Propionate	Fluticasone Propionate	42	18
Jardiance	Empagliflozin	40	11
Promethazine Hcl	Promethazine Hcl	40	suppressed
Atenolol	Atenolol	39	suppressed
Baclofen	Baclofen	39	15
Triamcinolone Acetonide	Triamcinolone Acetonide	39	13
Phenytoin Sodium Extended	Phenytoin Sodium Extended	38	suppressed
Spironolactone	Spironolactone	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	11
Meloxicam	Meloxicam	35	14
Pregabalin	Pregabalin	35	suppressed
Ventolin Hfa	Albuterol Sulfate	34	suppressed
Glipizide	Glipizide	33	suppressed
Lorazepam	Lorazepam	32	11
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	15
Topiramate	Topiramate	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Ipratropium Bromide	Ipratropium Bromide	30	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Myrbetriq	Mirabegron	28	suppressed
Cephalexin	Cephalexin	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Linzess	Linaclotide	27	suppressed
Invokana	Canagliflozin	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Valsartan	Valsartan	26	suppressed
Bupropion Hcl	Bupropion Hcl	25	suppressed
Famotidine	Famotidine	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	20
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Divalproex Sodium Er	Divalproex Sodium	19	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	19	suppressed
Morphine Sulfate	Morphine Sulfate	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Naloxone Hcl	Naloxone Hcl	18	15
Alogliptin	Alogliptin Benzoate	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Nystatin	Nystatin	17	suppressed
Amantadine	Amantadine Hcl	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Ozempic	Semaglutide	15	suppressed
Risperidone	Risperidone	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Cholestyramine Light	Cholestyramine	14	suppressed
Diazepam	Diazepam	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Belsomra	Suvorexant	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Thiothixene	Thiothixene	12	suppressed
Lovastatin	Lovastatin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Procto-Med Hc	Hydrocortisone	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error